CATHERINE TURNER: Open Payments
NPI 1386207256 · CHATOM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 26 payments from 8 companies in 2025. Trend: 2023 $672 · 2024 $514 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $143 |
| AstraZeneca Pharmaceuticals LP | 2 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| Corium, LLC | 3 | $52 |
| Lilly USA, LLC | 2 | $33 |
| ABBVIE INC. | 1 | $30 |
| Averitas Pharma Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Kerendia, AIRSUPRA, Rybelsus, Azstarys, Ozempic, Wegovy, MOUNJARO, UBRELVY.
Industry payments across AL — which companies pay providers there.
